It's understood that immune cells called helper T cells are overactive in patients with SLE. At last, scientists may have identified a crucial root cause of the problem. A rigorous study led by ...

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor–induced type 1 diabetes, ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Interferon gamma derived from cd4 (+) T cells is sufficient to mediate T helper cell type 1 development. J Exp Med. (1998) 188:1651–6. doi: 10.1084/jem.188.9.1651 ...

A, Uniform manifold approximation and projection plot displaying the major natural killer and T cell subtypes (including CD4 − CD8 − T, CD4 + CD8 + T, CD4 + T, CD8 + toxicity T, naïve T, memory T, ...

These immune cells — a subset of CD4+ T cells — are known as PD-1+CXCR5–CD4+ T cells ... Unlike conventional follicular helper T cells that work within germinal centres of lymph nodes, these newly ...

(12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) <li /> EO ...

Researchers mapped Y chromosome loss across thousands of individual cells from human cancers, with disturbing results.